Duality Advisers’s Avanos Medical AVNS Stock Holding History

Duality Advisers’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,846	Closed	-$679K	–	535
2022 Q2	$679K	Buy	+24,846	New	+$714K	0.07%	423

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Duality Advisers's AVNS Position: Q3 2022 in Review

Duality Advisers sold out of Avanos Medical (AVNS) in Q3 2022, closing a stake of 24,846 shares — an estimated $679K sold.

Duality Advisers first reported a position in AVNS in Q2 2022 and held it in 1 quarter. The position peaked at $679K in Q2 2022. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2022.

Duality Advisers reported no remaining Avanos Medical position as of Q3 2022 after selling out during the quarter.
Duality Advisers sold 24,846 Avanos Medical shares in Q3 2022, an estimated $679K.
Duality Advisers first reported a position in Avanos Medical in Q2 2022 and held it in 1 quarter.
Duality Advisers's Avanos Medical position peaked at $679K in Q2 2022.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2022.

Based on Duality Advisers's 13F filing for Q3 2022, filed 3 Nov 2022.